http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111100133-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F3-06 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-427 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18 |
filingDate | 2019-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2020-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2020-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-111100133-B |
titleOfInvention | A kind of metalloporphyrin compound and its preparation method and application |
abstract | The invention discloses a metalloporphyrin compound, a preparation method and application thereof, and belongs to the technical field of medicinal chemistry. The metalloporphyrin compound represented by formula I of the present invention, or its optical isomer, pharmaceutically acceptable salt or solvent compound, has specific HIV RNA recognition and excellent HIV reverse transcriptase inhibition ability. The application of the compound of the present invention in the preparation of HIV TAR RNA selective recognition reagent, and the application in the preparation of HIV reverse transcriptase inhibitor. |
priorityDate | 2019-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 119.